Cargando…
Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685422/ https://www.ncbi.nlm.nih.gov/pubmed/37882105 http://dx.doi.org/10.1097/CM9.0000000000002883 |
| _version_ | 1785151627014963200 |
|---|---|
| author | Zhu, Xueling Liu, Xiang Wan, Zhikai Hui, Jiangjin Tao, Ran Peng, Xiaorong Su, Junwei Huang, Ying Zhu, Biao |
| author_facet | Zhu, Xueling Liu, Xiang Wan, Zhikai Hui, Jiangjin Tao, Ran Peng, Xiaorong Su, Junwei Huang, Ying Zhu, Biao |
| author_sort | Zhu, Xueling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10685422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106854222023-11-30 Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study Zhu, Xueling Liu, Xiang Wan, Zhikai Hui, Jiangjin Tao, Ran Peng, Xiaorong Su, Junwei Huang, Ying Zhu, Biao Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-10-25 2023-11-20 /pmc/articles/PMC10685422/ /pubmed/37882105 http://dx.doi.org/10.1097/CM9.0000000000002883 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Zhu, Xueling Liu, Xiang Wan, Zhikai Hui, Jiangjin Tao, Ran Peng, Xiaorong Su, Junwei Huang, Ying Zhu, Biao Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title | Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title_full | Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title_fullStr | Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title_full_unstemmed | Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title_short | Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study |
| title_sort | safety and efficacy of pd-1 inhibitors in hiv-infected patients with severe comorbidities: a prospective observational cohort study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685422/ https://www.ncbi.nlm.nih.gov/pubmed/37882105 http://dx.doi.org/10.1097/CM9.0000000000002883 |
| work_keys_str_mv | AT zhuxueling safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT liuxiang safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT wanzhikai safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT huijiangjin safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT taoran safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT pengxiaorong safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT sujunwei safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT huangying safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy AT zhubiao safetyandefficacyofpd1inhibitorsinhivinfectedpatientswithseverecomorbiditiesaprospectiveobservationalcohortstudy |